Fig. 1From: Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetesThe cumulative incidences of liver-related death (a), mortality (b) between GLP-1 RA users and nonusersBack to article page